Simon Evans
Director Financiero/CFO en National Pharma Services .
Cargos activos de Simon Evans
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
National Pharma Services
 National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Director Financiero/CFO | 03/09/2010 | - |
Historial de carrera de Simon Evans
Antiguos cargos conocidos de Simon Evans.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DECHRA PHARMACEUTICALS | Director/Miembro de la Junta | 01/01/1997 | 19/10/2012 |
| Director Financiero/CFO | 01/01/1997 | 19/10/2012 |
Estadísticas
Internacional
| Reino Unido | 3 |
Operativa
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Dechra Pharmaceuticals Plc
 Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
National Pharma Services
National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Health Technology |
- Bolsa de valores
- Insiders
- Simon Evans
- Experiencia
